Workflow
泰林生物:向全资子公司增资1.09亿元

Core Viewpoint - The company has approved a capital increase for its wholly-owned subsidiary to support a new project focused on high-performance filters and functional membranes [1] Group 1: Company Actions - The company held its fourth board meeting on June 13, 2025, where it approved the proposal to use raised funds for capital increase [1] - The company will utilize surplus raised funds amounting to 109 million yuan, along with bank interest income and investment returns, to increase the capital of its subsidiary Zhejiang Tailin New Materials Co., Ltd [1] - The registered capital of Tailin New Materials will increase from 10 million yuan to 100 million yuan following this capital increase [1]